Changes in Life Expectancy of Respiratory Diseases from Attaining Daily PM2.5 Standard in China: A Nationwide Observational Study
- PMID: 34557725
- PMCID: PMC8454686
- DOI: 10.1016/j.xinn.2020.100064
Changes in Life Expectancy of Respiratory Diseases from Attaining Daily PM2.5 Standard in China: A Nationwide Observational Study
Abstract
Although exposure to air pollution increases the risk of premature mortality and years of life lost (YLL), the effects of daily air quality improvement to the life expectancy of respiratory diseases remained unclear. We applied a generalized additive model (GAM) to assess the associations between daily PM2.5 exposure and YLL from respiratory diseases in 96 Chinese cities during 2013-2016. We further estimated the avoidable YLL, potential gains in life expectancy, and the attributable fraction by assuming daily PM2.5 concentration decrease to the air quality standards of China and World Health Organization. Regional and national results were generated by random-effects meta-analysis. A total of 861,494 total respiratory diseases and 586,962 chronic obstructive pulmonary disease (COPD) caused death from 96 Chinese cities were recorded during study period. Each 10 μg/m3 increase of PM2.5 in 3-day moving average (lag02) was associated with 0.16 (95% CI: 0.08, 0.24) years increment in life expectancy from total respiratory diseases. The highest effect was observed in Southwest region with 0.42 (95% CI: 0.22, 0.62) years increase in life expectancy. By attaining the WHO's Air Quality Guidelines, we estimated that an average of 782.09 (95% CI: 438.29, 1125.89) YLLs caused by total respiratory death in each city could be avoided, which corresponded to 1.15% (95% CI: 0.67%, 1.64%) of the overall YLLs, and 0.12 (95% CI: 0.07, 0.17) years increment in life expectancy. The results of COPD were generally consistent with total respiratory diseases. Our findings indicate that reduction in daily PM2.5 concentrations might lead to longer life expectancy from respiratory death.
Keywords: China; chronic obstructive pulmonary disease; fine particulates; respiratory diseases; years of life lost.
© 2020.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Potential gains in life expectancy by attaining daily ambient fine particulate matter pollution standards in mainland China: A modeling study based on nationwide data.PLoS Med. 2020 Jan 17;17(1):e1003027. doi: 10.1371/journal.pmed.1003027. eCollection 2020 Jan. PLoS Med. 2020. PMID: 31951613 Free PMC article.
-
Improvement in life expectancy for ischemic heart diseases by achieving daily ambient PM2.5 standards in China.Environ Res. 2021 Feb;193:110512. doi: 10.1016/j.envres.2020.110512. Epub 2020 Nov 23. Environ Res. 2021. PMID: 33242488
-
Reduction in daily ambient PM2.5 pollution and potential life gain by attaining WHO air quality guidelines in Tehran.Environ Res. 2022 Jun;209:112787. doi: 10.1016/j.envres.2022.112787. Epub 2022 Jan 26. Environ Res. 2022. PMID: 35090875
-
The life expectancy benefits on respiratory diseases gained by reducing the daily concentration of particulate matter to attain different air quality standard targets: findings from a 5-year time-series study in Tianjin, China.Environ Sci Pollut Res Int. 2022 Sep;29(45):68870-68880. doi: 10.1007/s11356-022-20610-6. Epub 2022 May 12. Environ Sci Pollut Res Int. 2022. PMID: 35554809
-
How longer can people live by achieving the daily ambient fine particulate pollution standards in the Pearl River Delta region, China?Chemosphere. 2020 Sep;254:126853. doi: 10.1016/j.chemosphere.2020.126853. Epub 2020 Apr 21. Chemosphere. 2020. PMID: 32344230
Cited by
-
Urban-rural disparity of the short-term association of PM2.5 with mortality and its attributable burden.Innovation (Camb). 2021 Sep 30;2(4):100171. doi: 10.1016/j.xinn.2021.100171. eCollection 2021 Nov 28. Innovation (Camb). 2021. PMID: 34778857 Free PMC article.
-
Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019.Lancet Public Health. 2021 Dec;6(12):e897-e906. doi: 10.1016/S2468-2667(21)00228-0. Lancet Public Health. 2021. PMID: 34838196 Free PMC article.
-
Airborne particulate matters induce thrombopoiesis from megakaryocytes through regulating mitochondrial oxidative phosphorylation.Part Fibre Toxicol. 2021 May 13;18(1):19. doi: 10.1186/s12989-021-00411-4. Part Fibre Toxicol. 2021. PMID: 33985555 Free PMC article.
-
Associations of particulate matter with dementia and mild cognitive impairment in China: A multicenter cross-sectional study.Innovation (Camb). 2021 Jul 21;2(3):100147. doi: 10.1016/j.xinn.2021.100147. eCollection 2021 Aug 28. Innovation (Camb). 2021. PMID: 34557784 Free PMC article.
-
Association between long-term exposure to PM2.5 and thyroid nodules in school-aged children and adolescents: a cross-sectional study in Eastern China.Environ Health. 2025 Apr 7;24(1):18. doi: 10.1186/s12940-025-01172-9. Environ Health. 2025. PMID: 40197532 Free PMC article.
References
-
- Guan W.J., Zheng X.Y., Chung K.F., et al. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet. 2016;388:1939–1951. - PubMed
-
- Yang Y., Tang R., Qiu H., et al. Long term exposure to air pollution and mortality in an elderly cohort in Hong Kong. Environ. Int. 2018;117:99–106. - PubMed
-
- Lin H., Liu T., Xiao J., et al. Mortality burden of ambient fine particulate air pollution in six Chinese cities: results from the Pearl River Delta study. Environ. Int. 2016;96:91–97. - PubMed
-
- Wang C., Xu J., Yang L., et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–1717. - PubMed
LinkOut - more resources
Full Text Sources